The authorisation is issued for a period of five years; it is renewable for five-year periods under the conditions laid down in article R. 5141-137 of the same code.
It mentions the surname, first name and position of the authorisation holder, the name of the company or the name of the organisation which, where applicable, provides the facilities and the address of the preparation site.
It specifies the pathogens by target species, the pharmaceutical forms and the authorised adjuvants.